News

Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced the results from a preclinical study ...
Dan Hunt’s feelings about AMD run deep
Raising money for the Retina Foundation of the Southwest in Dallas is deeply personal for Dan Hunt, president of FC Dallas ...